Reduction of serum interleukin 7 levels upon methotrexate therapy in early rheumatoid arthritis correlates with disease suppression.
van Roon
J A G
JA
Jacobs
K
K
Verstappen
S
S
Bijlsma
J
J
Lafeber
F
F
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D015415:Biomarkers / Q000097:blood; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D015851:Interleukin-7 / Q000097:blood*; D008727:Methotrexate / Q000627:therapeutic use*; D016896:Treatment Outcome
D018501:Antirheumatic Agents; D015415:Biomarkers; D007166:Immunosuppressive Agents; D015851:Interleukin-7; D008727:Methotrexate